Michael Lowe, David Qian, Jeffrey Switchenko, Ryan J. Sullivan, Omid Hamid, Melinda Lynne Yushak, David H. Lawson, Nathaniel R. Wilson, Zachary Buchwald. "The TIME trial: Phase II randomized controlled trial of time-of-day–specified nivolumab and ipilimumab for advanced melanoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps2677